We’ve always hated the Ninth Circuit’s decision in Stengel v. Medtronic Inc., 704 F.3d 1224 (9th ..
Today we have another guest post by long-time friend of the blog, Dick Dean, and his partner at Tucker, ..
Not terribly long ago, we had a series of posts—too many to link—that recounted court decisions ..
Failure to warn claims premised on a failure to report incidents to a federal governing agency are preempted ..
Next week, under pressure from the Drug and Device Law Lifelong Best Friend, we are participating in a “murder ..
The toughest thing about defending product liability cases is the occasional immersion in human misery. ..
Recently, the Enviably Youthful Drug and Device Law Mother has been pushing us to plan a mother/daughter ..
Today’s guest post is by frequent contributor Dick Dean of the Tucker Ellis firm. This time, ..
We confess – when we first considered the spate of eye drop class actions a few years ago, we had trouble ..
We understand that we write a lot about federal preemption. You might even be rolling your eyes at yet another ..
Being that it was the Sixth Circuit that allowed a failure-to-update claim to proceed against a generic ..
Permit us to recount a recent travel misadventure, though whatever eventual connection we draw to today’s ..
We immediately called for the further appeal and reversal of the hideous decision in In re Fosamax (Alendronate ..
Prescription drug manufacturers are not insurers of injuries sustained while taking their products. Even ..